Human monoclonal antibodies to Fc gamma receptor I (CD64)

Details for Australian Patent Application No. 2005258336 (hide)

Owner Medarex, Inc.

Inventors Sundarapandiyan, Karuna; Graziano, Robert

Agent Shelston IP

Pub. Number AU-A-2005258336

PCT Pub. Number WO2006/002438

Priority 60/576,976 03.06.04 US

Filing date 3 June 2005

Wipo publication date 5 January 2006

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002438 Priority application(s): WO2006/002438

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005258339-Phenothiazine derivatives and their method of use

2005258335-Treatment of conditions involving demyelination